UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000037326
Receipt number R000042545
Scientific Title Biomarker study of a multicentre, open-label, randomized Phase III Study of Atezolizumab with Platinum-Pemetrexed with or without Bevacizumab for Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer WJOG11218L/APPLE (APPLE Biomarker study) (WJOG11218LTR)
Date of disclosure of the study information 2019/07/10
Last modified on 2021/01/11 08:52:47

No. Disposal Last modified on Item of update
1 Insert 2019/07/10 13:23:22
2 Update 2019/10/15 11:10:22 Recruitment status
Date of IRB
3 Update 2021/01/11 08:52:47 Recruitment status